The DRFZ has restructured its research areas and now comprises four areas. Two new program areas have been formed from the previously largest program area…
The DRFZ has restructured its research areas and now comprises four areas. Two new program areas have been formed from the previously largest program area…
Prof. Dr. Thomas Krieg is the new President of the Board of Trustees of the DRFZ, succeeding Prof. Dr. Elisabeth Märker-Hermann. Dr. med. Julia Rautenstrauch…
Prof. Dr. Chiara Romagnani, Liaison Group Leader at the DRFZ and Director of the Institute of Medical Immunology at Charité – Universitätsmedizin Berlin is a…
Only half of young rheumatology patients make the transition to adult medicine Only half of young rheumatology patients make the transition to adult medicineA survey…
Dear friends of mass cytometry, We cordially invite all mass cytometry enthusiasts to the 8th German Mass Cytometry User Forum on 11th – 12th of February 2025, taking…
The employment participation of people with inflammatory rheumatic diseases has increased since 2010. However, the employment rate is still below the population average. Carlo Veltri…
